CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will prospectively collect data from participants in the form of questionnaires. The registry will also capture data that is collected as per non-research assessments, for participants who consent to participate. The registry will facilitate better understanding of cancer risk, screening, and diagnostics.

NCT Number	NCT06804395
Lead Sponsor	Hackensack Meridian Health
Conditions	Cancer Risk
Enrollment	10,000 participants
Start Date	2024-10-01
Primary Completion	2034-10-01 (estimated)
Study Completion	2034-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-26